Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Colchicine and Low-dose Naltrexone on COVID-19 Disease Progression and Clinical Course in Hospitalized Patients

NCT04756128 is registered in ClinicalTrials.gov with HealthPartners Institute as lead sponsor.

NCT NCT04756128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04756128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Colchicine and Low-dose Naltrexone on COVID-19 Disease Progression and Clinical Course in Hospitalized Patients
Lead sponsor
HealthPartners Institute
Phase
Phase 2
Overall status
Completed
Start date
January 25, 2021
Completion date
December 12, 2021
Enrollment
142 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19